Cargando…
Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from Romania
Autores principales: | Streinu-Cercel, Adrian, Trifan, Anca Victorița, Căruntu, Florin Alexandru, Sporea, Ioan, Gheorghe, Liliana Simona, Curescu, Manuela, Diculescu, Mihai Mircea, Voiculescu, Mihai, Pascu, Oliviu, Lonjon-Domanec, Isabelle, Hill, Andrew Martin, Rugină, Sorin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882556/ http://dx.doi.org/10.1186/1471-2334-13-S1-P59 |
Ejemplares similares
-
Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the telaprevir early access program in patients from Romania
por: Streinu-Cercel, Adrian, et al.
Publicado: (2013) -
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
por: Colombo, M, et al.
Publicado: (2014) -
Seasonal and age-related variations impacting HPV vaccination uptake in Romania
por: Streinu-Cercel, Oana, et al.
Publicado: (2013) -
The seroprevalence of hepatitis E virus infection in the preselected population from Romania: a hospital survey
por: Gheorghiță, Valeriu, et al.
Publicado: (2014) -
Assessment of bacteriophage activity against local strains of Enterococcus and Pseudomonas in Romania
por: Neguț, Alina Cristina, et al.
Publicado: (2014)